Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Cow's milk allergy in multiple sclerosis patients.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Tropical myelopathies.
Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Safety of TNF inhibitors in adolescents and children.
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.
Contrast sensitivity in relapsing-remitting multiple sclerosis assessed by sine-wave gratings and angular frequency stimuli.
Symptomatic Thoracic Spinal Cord Herniation: Case Series and Technical Report.
Myelin organization in the nodal, paranodal, and juxtaparanodal regions revealed by scanning x-ray microdiffraction.
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Towards programming immune tolerance through geometric manipulation of phosphatidylserine.
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
Coping Mediates and Moderates the Relationship Between Executive Functions and Psychological Adjustment in Multiple Sclerosis .
Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Natalizumab therapy for multiple sclerosis.
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »